Latest filingSep 01, 2026Most recent Form 4
CRNX
Crinetics Pharmaceuticals, Inc.
NasdaqHealthcarePharmaceutical Preparations
Insider activity for last month from 08/03 to 09/03. Counts use processed Form 4 rows. Purchase and sale metrics use codes P and S; totals remain unknown when any matching value is missing. Rows without a usable transaction date cannot be assigned to a rolling period and are excluded.
Total buying$00 buys
Total selling$00 sells
Net open-market+$06 insiders
Open-market mix
Buy vs sell distribution by transaction countInsider activity report
Monthly open-market purchase and sale counts Buys Sells
Transaction codes
By Form 4 transaction code in selected period56transactions
- D · Issuer dispositions · dominant55 · 98%
- A · Grants / awards1 · 2%
Activity by reported role
A joint filing can contribute to multiple roles78transactions
- Chief executive officer · dominant17 · 22%
- Director17 · 22%
- PRES17 · 22%
- CSO13 · 17%
- CF5 · 6%
- IO5 · 6%
- CCO4 · 5%
Distinct insiders active
Reporting-owner CIKs by month · peak Sep 2026 (6)Aug 2026Sep 2026
Reported Holdings After
Separated by insider, security, and ownership typeBetz Stephen F.Stock Option (Right to Buy) · Direct
0Sep 01, 2026
Struthers Richard ScottStock Option (Right to Buy) · Direct
0Sep 01, 2026
Bedrosian Camille LStock Option (Right to Buy) · Direct
0Sep 01, 2026
Deardorf CarenStock Option (Right to Buy) · Direct
0Sep 01, 2026
Schilke TobinCommon Stock · Direct
71,471Sep 01, 2026
Struthers Richard ScottCommon Stock · Direct
0Sep 01, 2026
Schilke TobinStock Option (Right to Buy) · Direct
0Sep 01, 2026
Betz Stephen F.Common Stock · Direct
79,650Sep 01, 2026
These are reported post-transaction holdings, not company-wide ownership percentages. Securities, indirect vehicles, and amendments are kept separate.
Filing activity heatmap
Each cell is one day · intensity = transactions · buys green, sells redAug 03 → Sep 03
LessMore
Top insiders
By absolute net value across the selected period- SS-$149.4M
- BF-$59.7M
- ST-$12.9M
- KI-$9.6M
- BL-$8.6M
Recent filing activity
Most recent 12 transactions · color = transaction code- DIssuer disposition09/01-$47.8MSEC
- DIssuer disposition09/01-$54.5MSEC
- DIssuer disposition09/01-$50.3MSEC
- DIssuer disposition09/01-$113MSEC
- DIssuer disposition09/01-$29.1MSEC
- DIssuer disposition09/01-$229MSEC
- DIssuer disposition09/01-$50.3MSEC
- DIssuer disposition09/01-$138MSEC
- DIssuer disposition09/01-$47.8MSEC
- DIssuer disposition09/01-$54.5MSEC
- DIssuer disposition09/01-$50.3MSEC
- DIssuer disposition09/01-$113MSEC
Filing detail checks
Secondary metrics for the selected periodFiling-only signals
Deterministic matches in the selected period
CRNX transaction history
Filters apply within this company and selected period by default| Ticker | Insider | Role | Type | Shares | Value | Code | Signals | 90d return | Filed | Trans date |
|---|---|---|---|---|---|---|---|---|---|---|
| CRNX | Deardorf Caren | DIR | return | 9.73k | -$47.8M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Deardorf Caren | DIR | return | 10.3k | -$54.5M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Deardorf Caren | DIR | return | 12.5k | -$50.3M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Deardorf Caren | DIR | return | 17.5k | -$113M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Deardorf Caren | DIR | return | 4.37k | -$29.1M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Deardorf Caren | DIR | return | 35.0k | -$229M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Deardorf Caren | DIR | return | 5.92k | -$50.3M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Deardorf Caren | DIR | return | 16.3k | -$138M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Bedrosian Camille L | DIR | return | 9.73k | -$47.8M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Bedrosian Camille L | DIR | return | 10.3k | -$54.5M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Bedrosian Camille L | DIR | return | 12.5k | -$50.3M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Bedrosian Camille L | DIR | return | 17.5k | -$113M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Bedrosian Camille L | DIR | return | 17.5k | -$116M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Bedrosian Camille L | DIR | return | 17.5k | -$113M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Bedrosian Camille L | DIR | return | 25.0k | -$172M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Bedrosian Camille L | DIR | return | 5.92k | -$50.3M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Bedrosian Camille L | DIR | return | 16.3k | -$138M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Kalofonos Isabel | CCO | return | 55.0k | -$226M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Kalofonos Isabel | CCO | return | 97.5k | -$432M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Kalofonos Isabel | CCO | return | 34.0k | -$289M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Kalofonos Isabel | CCO | return | 1.66k | -$14.1M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 47.0k | -$193M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 65.0k | -$312M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 87.0k | -$360M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 110k | -$718M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 77.0k | -$500M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 15.0k | -$92.7M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 85.0k | -$592M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 60.0k | -$374M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 56.2k | -$336M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 74.5k | -$564M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 90.5k | -$752M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 79.6k | -$677M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Betz Stephen F. | CSO | return | 58.2k | -$495M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Schilke Tobin | CFIO | return | 50.0k | -$206M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Schilke Tobin | CFIO | return | 80.0k | -$410M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Schilke Tobin | CFIO | return | 71.4k | -$607M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Schilke Tobin | CFIO | return | 7.95k | -$67.6M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 228k | -$939M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 313k | -$1.50B | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 240k | -$995M | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 287k | -$1.88B | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 244k | -$1.58B | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 259k | -$1.80B | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 195k | -$1.22B | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 172k | -$1.03B | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 176k | -$1.50B | D | 0.0% | 09/01 | 09/01 | |
| CRNX | Struthers Richard Scott | PRESCEO | return | 80.0k | -$680M | D | — | 0.0% | 09/01 | 09/01 |
| CRNX | Struthers Richard Scott | PRESCEO | return | 111k | -$944M | D | — | 0.0% | 09/01 | 09/01 |
| CRNX | Struthers Richard Scott | PRESCEO | return | 100k | -$850M | D | — | 0.0% | 09/01 | 09/01 |
Crinetics Pharmaceuticals, Inc. Insider Activity FAQ
SEC Form 4 contextWho recently reported transactions at Crinetics Pharmaceuticals, Inc.?
Deardorf Caren, Bedrosian Camille L, Kalofonos Isabel, Betz Stephen F., Schilke Tobin, Struthers Richard Scott.
When was the latest reported open-market purchase?
No code-P purchase is available for this period.
When was the latest reported open-market sale?
No code-S sale is available for this period.
What is the recent purchase and sale balance?
No code-P purchases or code-S sales were reported in the selected period.
Where can I see the original SEC filing?
Every transaction row and latest-activity fact links to its original SEC filing.
What do these Form 4 transaction codes mean?
P and S generally describe open-market or private purchases and sales. A, D, F, M, X, G, J, and V describe awards, issuer dispositions, tax withholding, exercises, gifts, other transactions, and voluntary early reports; review each filing and its footnotes for context.